#antibody-drug conjugates

1 story

#aragen life sciences #cdmo capacity #contract research development manufactur #drug manufacturing #india pharmaceutical #initial public offering #manni kantipudi #oligonucleotides #peptides

Aragen bets big on complex drugs and IPO
Indian contract manufacturer plans 500 kilolitres of new capacity and moves into antibody-drug conjugates, peptides and oligonucleotides.
The Economic Times · 1m